France extends cheese recall after E.coli cases in children

PARIS (Reuters) – All Reblochon cheese coming from a factory in the French Alps should be removed from the market after young children were found to have been infected by a E.coli bacteria linked to the raw milk based product, the French agriculture ministry said on Monday.


Source: Reuters Medical News

U.S. to consider expanding Medicare drug price negotiation

WASHINGTON (Reuters) – The Trump administration is considering expanding Medicare’s ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines administered in hospitals and doctors’ offices, Health and Human Services Secretary Alex Azar said on Monday.


Source: Reuters Medical News

Migraine drug delay would compound Teva's troubles

TEL AVIV (Reuters) – Teva Pharmaceutical Industries is counting on its new migraine treatment to haul it out of the doldrums. But a possible delay in U.S. approval and looming pricing battle are making the task harder.


Source: Reuters Medical News

Ecstasy therapy may help service veterans suffering PTSD

(Reuters) – Combining intensive psychotherapy with a pure form of the party drug ecstasy is safe and could aid recovery in people with post-traumatic stress disorder (PTSD), according to the findings of a study in military veterans.


Source: Reuters Medical News

U.S. approves Novartis cell therapy for lymphoma

(Reuters) – U.S. regulators approved Novartis’ cell therapy Kymriah for treatment of patients with a second type of blood cancer, large B-cell lymphoma, that has worsened despite two or more earlier lines of therapy, the Swiss drugmaker said on Tuesday.


Source: Reuters Medical News